Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155680 | SCV000205390 | likely benign | not specified | 2013-04-21 | criteria provided, single submitter | clinical testing | Thr617Thr in exon 12 of TTN: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n this splice consensus sequence. Thr617Thr in exon 12 of TTN (allele frequency = n/a) |
Invitae | RCV002056099 | SCV002345930 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162635 | SCV003883434 | likely benign | Cardiovascular phenotype | 2023-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000155680 | SCV001925918 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701534 | SCV001927314 | likely benign | not provided | no assertion criteria provided | clinical testing |